Results 171 to 180 of about 23,536 (264)

Combined injectable regimens in treatment-experienced HIV/AIDS patients at a southern academic medical center: a case series. [PDF]

BMC Infect Dis
Burton HJ, Rivere E, Kirk S, Berry H, Lueking R.   +4 more
europepmc   +1 more source

Molecular transmission network analysis of HIV-1 among older adults in Central China: a cross-sectional study in Shaodong City. [PDF]

Front Microbiol
Zou X, Liu W, Zhou J, Zhang J, Chen J, Li J, Deng W, Chen H.   +7 more
europepmc   +1 more source

Adherence to antiretroviral therapy and drug resistance impact evolving viral suppression among a cohort of children and adolescents living with perinatal HIV infection in western Kenya. [PDF]

PLoS One
Vreeman R, Nyandiko W, DeLong A, Chory A, Scanlon M, Aluoch J, Sang E, Novitsky V, Sang F, Ashimosi C, Ayaya S, Jepkemboi E, Orido M, Hogan J, Kantor R.   +14 more
europepmc   +1 more source

Early outcomes of South African children with persistent viral non-suppression following switch to dolutegravir-based antiretroviral therapy. [PDF]

South Afr J HIV Med
Guerrini M, Maré M, Hulsman C, Greybe L, Lishman J, Edson C, Hisham T, Frigati L, Rabie H.   +8 more
europepmc   +1 more source

Baseline HIV Genotyping and Antiretroviral Therapy Resistance Mutations in Saudi Arabian Population, a Multicentre, Cross-Sectional Study. [PDF]

Viruses
Al-Osaimi R, Al-Qurashi M, Al-Zamil L, Ali B, Al-Mutairy R, Al-Saeed A, Al-Shelawi M, Al-Khalaf A, Al-Subaie A, Faqih L.   +9 more
europepmc   +1 more source

Genetic Subtypes, Pretreatment Drug Resistance, and Associated Factors Among Individuals Newly Diagnosed With HIV-1 in Zhejiang Province From 2022 to 2024: Cross-Sectional Study. [PDF]

JMIR Public Health Surveill
Cheng W, Fan Q, Zhang J, Jiang J, Yang J, Xu Y, Chen L, Chai C, Pan X.   +8 more
europepmc   +1 more source

Ninety-six-week observational outcomes of long-acting injectable HIV therapy in people with adherence challenges, including people who use drugs. [PDF]

AIDS
Ostrer L, Hastie E, Bamford L, Karim A, Martin NK, Hill L, Martin TCS.   +6 more
europepmc   +1 more source

Analysis of HIV Drug Resistance Mutations Along With Treatment Outcomes of Efavirenz-Based Regimens in Patients With V179D/E Mutations in Guangzhou, China. [PDF]

Can J Infect Dis Med Microbiol
Zheng X, Xiao Y, Zhang Y, Wang P, Zhang Y, Li L, Zheng Y, Li X, Chen D, Yang X, Huang Z.   +10 more
europepmc   +1 more source

A French National Real-World Survey of People With Multiresistant HIV-1 Viruses Receiving an Antiretroviral Regimen Including Fostemsavir or Ibalizumab. [PDF]

Open Forum Infect Dis
Stefic K, Tumiotto C, de Monte A, Wirden M, Rodallec A, Fofana D, Chaix ML, Bellecave P, Garnier E, Sourice J, Vellas C, Raymond S, Lambert-Niclot S, Alidjinou EK, Coulon P, Avettand-Fenoel V, Mchantaf G, Handala L, Alessandri-Gradt E, Moisan A, Lê M, Delaugerre C, Marcelin AG, Peytavin G, Calvez V, Descamps D, Charpentier C, Entry Inhibitors Observatory Study Group, Entry Inhibitors Observatory Study Group .   +28 more
europepmc   +1 more source

Changes in RPV Resistance-Related Mutations Among Antiretroviral Therapy-Naïve HIV-1-Positive Individuals - China, 2004-2023. [PDF]

China CDC Wkly
Li X, Liu X, Xin P, Wang D, Hao J, Song C, Hu J, Feng Y, Ruan Y, Xing H, Liao L.   +10 more
europepmc   +1 more source